Aramark
NYSE:ARMKSpecialty Business Services
-$0.88 today
- Market cap
- $14.99B
- Beta
- 1.19
- P/E (TTM)
- 39.4
- EPS (TTM)
- $1.36
- Dividend yield
- 0.87%
Volume 3.37M
Average 2.79M
ARMK EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
AramarkNYSE: ARMK
EBITDA · Q4 FY2026 · quarter ended Oct 2026
EBITDA growth accelerates
Q4 FY2026 EBITDA of $403.73M rose 25.1% year over year, ahead of the +16.7% change in trailing-twelve-month EBITDA. Sequentially, it rose 14.8% from the prior quarter. Over 3 fiscal years it compounded at +0.2% a year.
Context
- EBITDA amounted to 7.2% of revenue in FY2026, up 0.5 pp from a year earlier.
- EBITDA increased in 2 of the last 3 fiscal years.
- FY2026 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 12 analysts of $1.83B (+26.4%) for the fiscal year ending Oct 2027, a step up from the +16.0% reported in FY2026.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterOct 2026
- $403.73M+14.8% QoQ
- Last fiscal yearOct 2026
- $1.45B+16.0% YoY
- LTMOct 2026
- $1.46B+16.7% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +25.1% | +22.1% | -3.1 pp |
| 1 year | +16.0% | +26.4% | +10.4 pp |
| 3-year CAGR | +0.2% | +14.6% | +14.5 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2026
- 1.45B USD
- Year-over-year change
- +16.0%
- 4-year CAGR
- +10.7%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2026 | 2026-10-02 | 1.45B | +16.0% |
| FY2025 | 2025-10-03 | 1.25B | +5.0% |
| FY2024 | 2024-09-30 | 1.19B | -17.4% |
| FY2023 | 2023-09-30 | 1.44B | +49.4% |
| FY2022 | 2022-09-30 | 964.4M | — |
EBITDA vs competitors
How ARMK compares with its peers on the latest reported figures
- ARMK's LTM Oct 2026 EBITDA of $1.46B is the 2nd highest of the 3 companies compared; the peer median is $1.83B.
- Its year-over-year change of +16.7% is the highest of 3, against a peer median of -1.4%.
- EBITDA amounts to 7.3% of revenue for ARMK, versus a peer median of 16.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Aug 2026 | $3.22B | +10.2% | +12.0% | 27.8% | |
| LTM Oct 2026 | $1.46B | +16.7% | +0.2% | 7.3% | |
| LTM Jul 2026 | $437.5M | -13.0% | -2.9% | 4.8% | |
| Peer median (excluding ARMK) | $1.83B | -1.4% | +4.6% | 16.3% | |
Competitors are the stored peer set for ARMK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Sep 2022 | FY2023 Sep 2023 | FY2024 Sep 2024 | FY2025 Oct 2025 | FY2026 Oct 2026 |
|---|---|---|---|---|---|
| Revenue | 13.69B | 16.08B | 17.4B | 18.51B | 20.09B |
| Cost of Revenue | 12.62B | 14.77B | 15.98B | 17.44B | 18.32B |
| Gross Profit | 1.07B | 1.31B | 1.43B | 1.07B | 1.77B |
| Gross Margin | 7.8% | 8.1% | 8.2% | 5.8% | 8.8% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 258.36M | 273.66M | 283.63M | 278.44M | 0 |
| Operating Expenses | 656.33M | 683.52M | 719.17M | 278.44M | 850.84M |
| Depreciation & Amortization | 532.33M | 409.86M | 435.55M | 476.35M | 533.58M |
| EBITDA | 964.4M | 1.44B | 1.19B | 1.25B | 1.45B |
| EBITDA Margin | 7.0% | 9.0% | 6.8% | 6.7% | 7.2% |
| Operating Income | 415.39M | 625.03M | 706.51M | 791.85M | 917.27M |
| Operating Margin | 3.0% | 3.9% | 4.1% | 4.3% | 4.6% |
| Interest Income | 16.68M | 29.81M | 22.48M | 22.45M | 0 |
| Interest Expense | 384.86M | 467.29M | 389.19M | 364.38M | 321.39M |
| Other Income / Expenses | (368.18M) | (61.5M) | (341.65M) | (361.39M) | (321.39M) |
| Income Before Tax | 47.21M | 563.52M | 364.87M | 430.46M | 595.88M |
| Pre-Tax Margin | 0.3% | 3.5% | 2.1% | 2.3% | 3.0% |
| Income Tax Expense | 8.43M | 116.43M | 102.97M | 103.59M | 159.49M |
| Net Income | 194.48M | 674.11M | 262.52M | 326.39M | 433.71M |
| Net Margin | 1.4% | 4.2% | 1.5% | 1.8% | 2.2% |
| EPS (Basic) | 0.76 | 2.59 | 1.00 | 1.24 | 1.65 |
| EPS (Diluted) | 0.75 | 2.57 | 0.99 | 1.22 | 1.62 |
| Weighted Avg Shares | 257.31M | 260.59M | 263.05M | 263.86M | 263.49M |
| Weighted Avg Shares (Diluted) | 259.07M | 262.59M | 266.2M | 267.35M | 268.03M |
Aramark
NYSE:ARMK
Intrinsic Alpha fair value
Locked
Current Price
$56.85
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.